Northeast Pharmaceutical Group Co., Ltd.

SZSE:000597 Stock Report

Market Cap: CN¥8.1b

Northeast Pharmaceutical Group Management

Management criteria checks 2/4

Northeast Pharmaceutical Group's CEO is Zhou Kai, appointed in May 2019, has a tenure of 5.58 years. directly owns 0.3% of the company’s shares, worth CN¥23.97M. The average tenure of the management team and the board of directors is 1.4 years and 5.1 years respectively.

Key information

Zhou Kai

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenure5.6yrs
CEO ownership0.3%
Management average tenure1.4yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

We Think Northeast Pharmaceutical Group (SZSE:000597) Can Manage Its Debt With Ease

Dec 02
We Think Northeast Pharmaceutical Group (SZSE:000597) Can Manage Its Debt With Ease

Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597) Soars 27% But It's A Story Of Risk Vs Reward

Nov 08
Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597) Soars 27% But It's A Story Of Risk Vs Reward

Northeast Pharmaceutical Group's (SZSE:000597) Weak Earnings May Only Reveal A Part Of The Whole Picture

Oct 30
Northeast Pharmaceutical Group's (SZSE:000597) Weak Earnings May Only Reveal A Part Of The Whole Picture

It's A Story Of Risk Vs Reward With Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597)

Aug 07
It's A Story Of Risk Vs Reward With Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597)

These 4 Measures Indicate That Northeast Pharmaceutical Group (SZSE:000597) Is Using Debt Safely

May 25
These 4 Measures Indicate That Northeast Pharmaceutical Group (SZSE:000597) Is Using Debt Safely

Northeast Pharmaceutical Group (SZSE:000597) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Apr 05
Northeast Pharmaceutical Group (SZSE:000597) Is Posting Promising Earnings But The Good News Doesn’t Stop There

CEO

Zhou Kai (60 yo)

5.6yrs

Tenure

CN¥1,824,100

Compensation

Mr. Zhou Kai serves as a General Manager of Northeast Pharmaceutical Group Co., Ltd. since May 8, 2019 and serves its Non-Independent Director since November 29, 2020. He served as a Vice President of Nort...

Leadership Team

NamePositionTenureCompensationOwnership
Zhou Kai
GM & Director5.6yrsCN¥1.82m0.30%
CN¥ 24.0m
Jialun Song
Financial Director & Secretary1.8yrsCN¥2.14m0.022%
CN¥ 1.8m
Xiao Feng
Deputy General Managerless than a yearCN¥894.30kno data
Yonggang Cai
Deputy General Managerless than a yearno datano data

1.4yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 000597's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Zhou Kai
GM & Director4.1yrsCN¥1.82m0.30%
CN¥ 24.0m
Demin Han
Independent Director6.4yrsCN¥150.00kno data
Zhaochun Tan
Non-Independent Director3.1yrsno datano data
Chengren Huang
Non-Independent Director6.4yrsno data0.23%
CN¥ 18.3m
Xinhua Ao
Non-Independent Director6.4yrsno data0.23%
CN¥ 18.3m
Guodong Wang
Independent Director6.4yrsCN¥150.00kno data
Hui Yao
Independent Director6.4yrsCN¥150.00kno data
Youguang Shang
Independent Director4.2yrsCN¥150.00kno data
Jianmin Guo
Chairman of the Board3.2yrsCN¥2.07m0.22%
CN¥ 18.1m
Zhihua Huang
Non-Independent Director3.1yrsno data0.070%
CN¥ 5.7m
Baidan Zhan
Chairman of the Supervisory Board6yrsno datano data
Hai Tian
Director1.3yrsno datano data

5.1yrs

Average Tenure

59yo

Average Age

Experienced Board: 000597's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 07:45
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Northeast Pharmaceutical Group Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jie YaoCitic Securities Co., Ltd.
Xiaoming LiuGuoyuan Securities Co., Ltd.
Yining ZhengTopsperity Securities